News

The two collaborated on research showing that quantum computing could greatly aid the design of mRNA-based medicines and ...
International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum ...
IBM and Moderna announced a new partnership today to explore the potential of generative AI and quantum computing. ... Garcia noted that Moderna is now part of the IBM Quantum Accelerator program, ...
Moderna invests in developing quantum computing skills and exploring the use of quantum computing in developing future mRNA medicines Agreement with IBM includes investments in generative AI to ...
Investment firms have issued research reports regarding IBM's earnings release, including RBC Capital, which raised its price ...
Moderna and IBM are joining forces to incorporate artificial intelligence (AI) and quantum computing into mRNA development, which was used to create Moderna’s COVID-19 vaccine. “We are … ...
Moderna and IBM have formed a partnership to see how cutting-edge technologies like generative artificial intelligence and quantum computing could be applied to the discovery of mRNA medicines.
Moderna Teams Up With IBM to Put A.I., Quantum Computing to Work on MRNA Technology Used in Vaccines By Annika Kim Constantino,CNBC • Published April 20, 2023 • Updated on April 20, 2023 at 11 ...
Through the partnership, Moderna will have access to IBM’s quantum computers. Additionally, Moderna and IBM scientists will use the MoLFormer AI model to help predict molecules’ properties and ...
"We are excited to partner with IBM to develop novel AI models to advance mRNA science, prepare ourselves for the era of quantum computing, and ready our business for these game-changing technologies.
"IBM's purpose is to be the catalyst to make the world work better, perfectly exemplified by this partnership with Moderna. We are witnessing a revolution in the world of computing, driven by ...
Under the agreement, IBM will provide access to quantum computing systems, as well as expertise to assist Moderna in exploring cutting-edge life sciences use-cases powered by quantum technologies.